These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 19666904

  • 1. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S, Ishidoya S, Ito A, Tochigi T, Numata I, Narazaki K, Yamada S, Takai Y, Arai Y.
    Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
    [Abstract] [Full Text] [Related]

  • 2. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.
    Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, Yoshimura K, Numata I, Satoh M, Saito S, Takai Y, Yamada S, Arai Y.
    Jpn J Clin Oncol; 2006 Apr; 36(4):224-30. PubMed ID: 16537689
    [Abstract] [Full Text] [Related]

  • 3. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I, Dehnad H, Kruger AB, van Moorselaar J, van der Heide U, Battermann J, van Vulpen M.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):656-61. PubMed ID: 17512127
    [Abstract] [Full Text] [Related]

  • 4. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.
    Namiki S, Tochigi T, Kuwahara M, Ioritani N, Terai A, Numata I, Satoh M, Saito S, Koinuma N, Arai Y.
    Int J Urol; 2004 Aug 01; 11(8):619-27. PubMed ID: 15285752
    [Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):654-62. PubMed ID: 17011444
    [Abstract] [Full Text] [Related]

  • 6. Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy.
    Yoshimura K, Kamoto T, Nakamura E, Segawa T, Kamba T, Takahashi T, Nishiyama H, Ito N, Takayama K, Mizowaki T, Mitsumori M, Hiraoka M, Ogawa O.
    Prostate Cancer Prostatic Dis; 2007 Nov 01; 10(3):288-92. PubMed ID: 17160068
    [Abstract] [Full Text] [Related]

  • 7. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A, Valcárcel F, Calvo FA, Algás R, Béjar A, Maldonado J, Villá S.
    J Clin Oncol; 2005 Sep 20; 23(27):6561-8. PubMed ID: 16170164
    [Abstract] [Full Text] [Related]

  • 8. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):1-8. PubMed ID: 19111400
    [Abstract] [Full Text] [Related]

  • 9. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):725-31. PubMed ID: 16199308
    [Abstract] [Full Text] [Related]

  • 10. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy.
    Staff I, Salner A, Bohannon R, Panatieri P, Maljanian R.
    Cancer; 2003 Dec 01; 98(11):2335-43. PubMed ID: 14635067
    [Abstract] [Full Text] [Related]

  • 11. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.
    J Urol; 2007 Jun 01; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [Abstract] [Full Text] [Related]

  • 12. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F, Multicentric Spanish Group of Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):421-32. PubMed ID: 18325680
    [Abstract] [Full Text] [Related]

  • 13. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S, Satoh T, Baba S, Ishiyama H, Hayakawa K, Saito S, Arai Y.
    Urology; 2006 Dec 01; 68(6):1230-6. PubMed ID: 17141839
    [Abstract] [Full Text] [Related]

  • 14. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V, Bourdin S, Charbonnel C, Rio E, Munos C, Campion L, Bonnaud-Antignac A, Lisbona A, Mahé MA, Supiot S.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):1053-9. PubMed ID: 19880259
    [Abstract] [Full Text] [Related]

  • 15. Quality of life outcomes after brachytherapy for early stage prostate cancer.
    Brandeis JM, Litwin MS, Burnison CM, Reiter RE.
    J Urol; 2000 Mar 15; 163(3):851-7. PubMed ID: 10687991
    [Abstract] [Full Text] [Related]

  • 16. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R, Chhatre S, Whittington R, Bloom BS, Wein AJ, Malkowicz SB.
    BJU Int; 2006 May 15; 97(5):955-62. PubMed ID: 16643477
    [Abstract] [Full Text] [Related]

  • 17. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
    Namiki S, Saito S, Tochigi T, Ioritani N, Terai A, Arai Y.
    Int J Urol; 2007 Mar 15; 14(3):186-91. PubMed ID: 17430252
    [Abstract] [Full Text] [Related]

  • 18. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
    Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Holy R, Krenkel B, Eble MJ.
    Radiother Oncol; 2008 Jul 15; 88(1):135-9. PubMed ID: 18022263
    [Abstract] [Full Text] [Related]

  • 19. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy.
    Alongi F, Fiorino C, Cozzarini C, Broggi S, Perna L, Cattaneo GM, Calandrino R, Di Muzio N.
    Radiother Oncol; 2009 Nov 15; 93(2):207-12. PubMed ID: 19766338
    [Abstract] [Full Text] [Related]

  • 20. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
    Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP.
    J Urol; 2003 Nov 15; 170(5):1822-7. PubMed ID: 14532784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.